BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38698330)

  • 21. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling.
    Hu S; Ren S; Cai Y; Liu J; Han Y; Zhao Y; Yang J; Zhou X; Wang X
    Cell Death Differ; 2022 Mar; 29(3):642-656. PubMed ID: 34743203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK.
    Cui L; Lu Y; Zheng J; Guo B; Zhao X
    J Exp Clin Cancer Res; 2023 Dec; 42(1):335. PubMed ID: 38057867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas.
    Que T; Zheng H; Zeng Y; Liu X; Qi G; La Q; Liang T; Li Z; Yi G; Zhang S; Li J; Nie J; Tan JE; Huang G
    Cell Death Dis; 2021 Dec; 12(12):1147. PubMed ID: 34887392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
    Zhang H; Liu S; Tang L; Ge J; Lu X
    Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma.
    Yang P; Zhang P; Zhang S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma.
    Chen P; Xing T; Wang Q; Liu A; Liu H; Hu Y; Ji Y; Song Y; Wang D
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31533968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M; Liao X; Li L; Li G; Chen M
    Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
    Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
    Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
    Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
    Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BARX1 repressed FOXF1 expression and activated Wnt/β-catenin signaling pathway to drive lung adenocarcinoma.
    Guan X; Liang J; Xiang Y; Li T; Zhong X
    Int J Biol Macromol; 2024 Mar; 261(Pt 2):129717. PubMed ID: 38290639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity.
    Nian Y; Li X; Ma J; Gao T; Liu D
    J Gynecol Oncol; 2023 Jan; 34(1):e11. PubMed ID: 36424704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
    J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX17 is a tumor suppressor in endometrial cancer.
    Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
    Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.
    Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R
    EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DLGAP5 knockdown inactivates the Wnt/β-catenin signal to repress endometrial cancer cell malignant activities.
    Chen R; Liu J; Hu J; Li C; Liu Y; Pan W
    Environ Toxicol; 2023 Mar; 38(3):685-693. PubMed ID: 36454672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
    Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
    Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogel-based miR-192 delivery inhibits the development of hepatocellular carcinoma by suppressing the GSK3β/Wnt/β-catenin pathway.
    Yang Q; Zhuge X; Lin W; Yu W; Zhu Y; Shi C; Shi Z
    Neoplasma; 2023 Aug; 70(4):555-565. PubMed ID: 37789778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.